News Updates

More Articles Back to Article

Astellas, Sony to collaborate on antibody-drug conjugate

Astellas Pharma has partnered with Sony for the development of a platform for a novel antibody-drug conjugate for cancer therapeutics. Sony's biotech R&D arm and Astellas will leverage Kiravia Backbone, a novel polymeric material, which will act as a linker for the novel ADC. BioSpace (San Francisco) (5/16)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!